Product Code: ETC9967688 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Hereditary Cancer Testing Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Hereditary Cancer Testing Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Hereditary Cancer Testing Market - Industry Life Cycle |
3.4 United States (US) Hereditary Cancer Testing Market - Porter's Five Forces |
3.5 United States (US) Hereditary Cancer Testing Market Revenues & Volume Share, By Test Type, 2021 & 2031F |
3.6 United States (US) Hereditary Cancer Testing Market Revenues & Volume Share, By Diagnosis Type, 2021 & 2031F |
3.7 United States (US) Hereditary Cancer Testing Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.8 United States (US) Hereditary Cancer Testing Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 United States (US) Hereditary Cancer Testing Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 United States (US) Hereditary Cancer Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of early cancer detection |
4.2.2 Growing prevalence of hereditary cancer cases in the US population |
4.2.3 Technological advancements leading to more accurate and affordable testing options |
4.3 Market Restraints |
4.3.1 High cost associated with hereditary cancer testing limiting accessibility |
4.3.2 Limited insurance coverage for genetic testing leading to out-of-pocket expenses |
4.3.3 Regulatory challenges related to genetic testing and data privacy concerns |
5 United States (US) Hereditary Cancer Testing Market Trends |
6 United States (US) Hereditary Cancer Testing Market, By Types |
6.1 United States (US) Hereditary Cancer Testing Market, By Test Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Hereditary Cancer Testing Market Revenues & Volume, By Test Type, 2021- 2031F |
6.1.3 United States (US) Hereditary Cancer Testing Market Revenues & Volume, By Multi Panel Set, 2021- 2031F |
6.1.4 United States (US) Hereditary Cancer Testing Market Revenues & Volume, By Single Site Genetic Test, 2021- 2031F |
6.2 United States (US) Hereditary Cancer Testing Market, By Diagnosis Type |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Hereditary Cancer Testing Market Revenues & Volume, By Biopsy, 2021- 2031F |
6.2.3 United States (US) Hereditary Cancer Testing Market Revenues & Volume, By Imaging, 2021- 2031F |
6.2.4 United States (US) Hereditary Cancer Testing Market Revenues & Volume, By Lab Tests, 2021- 2031F |
6.3 United States (US) Hereditary Cancer Testing Market, By Technology |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Hereditary Cancer Testing Market Revenues & Volume, By Sequencing, 2021- 2031F |
6.3.3 United States (US) Hereditary Cancer Testing Market Revenues & Volume, By Polymerase Chain Reaction (PCR), 2021- 2031F |
6.3.4 United States (US) Hereditary Cancer Testing Market Revenues & Volume, By Microarray, 2021- 2031F |
6.4 United States (US) Hereditary Cancer Testing Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Hereditary Cancer Testing Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 United States (US) Hereditary Cancer Testing Market Revenues & Volume, By Clinics, 2021- 2031F |
6.4.4 United States (US) Hereditary Cancer Testing Market Revenues & Volume, By Laboratories, 2021- 2031F |
6.4.5 United States (US) Hereditary Cancer Testing Market Revenues & Volume, By Radiology Centers, 2021- 2031F |
6.4.6 United States (US) Hereditary Cancer Testing Market Revenues & Volume, By Diagnostic Centers, 2021- 2031F |
6.4.7 United States (US) Hereditary Cancer Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.5 United States (US) Hereditary Cancer Testing Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 United States (US) Hereditary Cancer Testing Market Revenues & Volume, By Direct Tender, 2021- 2031F |
6.5.3 United States (US) Hereditary Cancer Testing Market Revenues & Volume, By Retail Sales, 2021- 2031F |
7 United States (US) Hereditary Cancer Testing Market Import-Export Trade Statistics |
7.1 United States (US) Hereditary Cancer Testing Market Export to Major Countries |
7.2 United States (US) Hereditary Cancer Testing Market Imports from Major Countries |
8 United States (US) Hereditary Cancer Testing Market Key Performance Indicators |
8.1 Average cost per test |
8.2 Adoption rate of hereditary cancer testing by healthcare providers |
8.3 Patient satisfaction and trust in the accuracy of test results |
9 United States (US) Hereditary Cancer Testing Market - Opportunity Assessment |
9.1 United States (US) Hereditary Cancer Testing Market Opportunity Assessment, By Test Type, 2021 & 2031F |
9.2 United States (US) Hereditary Cancer Testing Market Opportunity Assessment, By Diagnosis Type, 2021 & 2031F |
9.3 United States (US) Hereditary Cancer Testing Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.4 United States (US) Hereditary Cancer Testing Market Opportunity Assessment, By End User, 2021 & 2031F |
9.5 United States (US) Hereditary Cancer Testing Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 United States (US) Hereditary Cancer Testing Market - Competitive Landscape |
10.1 United States (US) Hereditary Cancer Testing Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Hereditary Cancer Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |